Translocation and downregulation of protein kinase C isoenzymes-alpha and -epsilon by phorbol ester and bryostatin-1 in human keratinocytes and fibroblasts. 1994

N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
Department of Dermatology, University of Michigan, Ann Arbor 48109.

Protein kinase C isoenzymes can be subdivided into two classes, based on their requirement for calcium. Protein kinase C-alpha, beta I, -beta II, and -gamma are calcium dependent, whereas protein kinase C-gamma, -epsilon, -zeta, -eta, and -theta are calcium independent. We have examined the expression, translocation, downregulation, and activation of calcium-dependent and -independent protein kinase C isoenzymes in human skin keratinocytes and fibroblasts. Human keratinocytes and fibroblasts expressed protein kinase C-alpha, -delta, -epsilon, and -zeta mRNA and protein, whereas protein kinase C-eta (L) was detected only in keratinocytes. Protein kinase C-beta I, -beta II, -gamma, and -theta were not detected in either cell type. The protein kinase C activators 12-0-tetradecanoylphorbol 13-acetate and bryostatin-1 (50 nM, for 5 min) induced translocation of protein kinase C-alpha and -epsilon cytosol to membrane in both keratinocytes and fibroblasts. 12-0-tetradecanoylphorbol 13-acetate and bryostatin-1, for 18 h, induced complete downregulation (i.e., loss) of protein kinase C-alpha and -epsilon in keratinocytes, but only partial downregulation was observed in fibroblasts. The subcellular distribution of protein kinase C-delta, -zeta or protein kinase C-eta, in keratinocytes or fibroblasts, did not change in response to 12-0-tetradecanoylphorbol 13-acetate or bryostatin-1. These data indicate differential expression, subcellular distribution, and regulation of protein kinase C isoenzymes in human skin cells.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic

Related Publications

N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
March 1997, Molecular pharmacology,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
November 1988, The Tohoku journal of experimental medicine,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
March 1993, Biochemical and biophysical research communications,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
January 1991, Molecular carcinogenesis,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
August 1997, Biochemical Society transactions,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
September 1987, Experimental cell research,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
November 1994, Molecular pharmacology,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
February 1988, FEBS letters,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
October 1997, European journal of biochemistry,
N J Reynolds, and J J Baldassare, and P A Henderson, and J L Shuler, and L M Ballas, and D J Burns, and C R Moomaw, and G J Fisher
September 2010, Molecular pharmacology,
Copied contents to your clipboard!